Archives for June 2007
Strong Showing of Healthcare Firms on FSB 100
Fortune Small Business is out with its annual FSB 100, a list of the most successful small public companies in the U.S. Almost a quarter of the list (21 companies) is made up of healthcare-related enterprises. Here’s a look at who made the cut and what makes them worthy:
Palomar Medical Technologies, ranked number 8, […]
Michigan Firms Band Together to Support Startups
Medical device manufacturers in western Michigan are coming together to support the region’s life sciences startups.
Seven local companies have created the West Michigan Medical Device Consortium, a membership organization designed to assist small firms with product innovation, business collaboration, marketing and lean manufacturing technologies. The effort is backed by the West Michigan Science & Technology […]
Pervasis Technology More than a ‘Stentless Stent’
Pervasis Therapeutics, a Cambridge, MA, firm whose endothelial cell technology is shown to reverse vascular dysfunction and disruption, is working on a product that could serve as a viable alternative to controversial drug-eluting stents. But the company’s brass tells Technology Review this week that the product, Vascugel, shouldn’t be thought of as “just a ’stentless […]
Against Odds, CryoCor Gets Advisory Panel Nod
Two days after CryoCor got word that FDA was not satisfied with safety and efficacy data for the company’s Cryoablation System, the agency’s advisory panel recommended the device for approval. FDA is not required to follow the advice of its advisors, but it typically does. A final decision by FDA is expected in August.
San […]
North Carolina Firm Puts New Twist on Brachytherapy
CivaTech Oncology, a startup based in Research Triangle Park, NC, that’s developing a device for delivering more consistent radiation to prostate-cancer patients, has raised $800,000 in an oversubscribed private financing.
The funding demonstrates angel investors’ confidence in the firm’s technology, which puts a new twist on brachytherapy. Typically, brachytherapy, a type of radiation treatment for cancer […]
Cytori Forgoes Drugs for Devices
Cytori Therapeutics may be on to something. The San Diego firm is using stem and regenerative cell therapies to develop products for treating cardiovascular disease and performing reconstructive surgery. But unlike so many stem cell companies that are looking to commercialize their technologies through drugs, Cytori is taking a quicker and less grueling route, by […]
New Reports Predict Growth for Device Sector
BBC Research is out with a few reports that look at the medical device sector — and make hopeful predictions.
One, “The Global Market for Pain Management Drugs and Devices,” says devices account for only a small sliver of the pain-management pie — $1.87 billion in 2007, compared with $29 billion for pharmaceuticals. Devices, though, are […]
CardioDynamics Streamlines ICG Business
CardioDynamics, a San Diego-based company that uses impedance cardiography (ICG) technology to monitor the heart’s ability to deliver blood to the body, has decided to sell its Vermed subsidiary for $8 million.
The move allows CardioDynamics to focus exclusively on its ICG business and BioZ product line. BioZ diagnostics, modules and monitors measure blood as it […]
FDA Gives CryoCor the Cold Shoulder
San Diego-based CryoCor suffered a blow today, when it learned that FDA is yet again unhappy with the company’s pre-market approval application for its Cryoblation System, which uses extreme cold to treat cardiac arrhythmias. The news came two days before CryoCor was scheduled to present clinical data at an FDA advisory panel meeting.
CryoCor is seeking […]
Shelhigh Consent Agreement Stops Short of Recall
Shelhigh has agreed to stop distributing its implantable devices, roughly two months after FDA seized products made at the company’s Union, NJ, manufacturing facility. Under a court order signed last Friday, Shelhigh is required to hire independent consultants to inspect its facility and certify to FDA that everything is up to snuff. The order, though, […]
